Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls

Epigenetics

Volumn 7, Issue 11, 2012, Pages 1258-1267

  Sturgeon, Susan R ^a   Balasubramanian, Raji ^a   Schairer, Catherine ^b   Muss, Hyman B ^c   Ziegler, Regina G ^b   Arcaro, Kathleen F ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Breast cancer; Early marker; Promoter methylation; Pyrosequencing; Serum DNA

Indexed keywords

EID: 84868368069     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.22220     Document Type: Article

References (25)

1. Levenson VV. Biomarkers for early detection of breast cancer: what, when, and where? Biochim Biophys Acta 2007. 1770:847-856. PMID:17368950. http://dx.doi.org/10.1016/j.bbagen.2007.01.017.
2. Suijkerbuijk KP, van Diest PJ, van der Wall E. Improving early breast cancer detection: focus on methylation. Ann Oncol 2011. 22:24-29. PMID:20591821. http://dx.doi.org/10.1093/annonc/mdq305.
3. Widschwendter M, Jones PA. DNA methylation and breast carcinogenesis. Oncogene 2002. 21:5462-5482. PMID:12154408. http://dx.doi.org/10.1038/sj.onc.1205606.
4. Campan M, Weisenberger DJ, Laird PW. DNA methylation profiles of female steroid hormone-driven human malignancies. Curr Top Microbiol Immunol 2006. 310:141-178. PMID:16909910. http://dx.doi.org/10.1007/3-540-31181-5_8.
5. Fackler MJ, McVeigh M, Mehrotra J, Blum MA, Lange J, Lapides A, et al. Quantitative multiplex methylationspecific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 2004. 64:4442-4452. PMID:15231653. http://dx.doi.org/10.1158/0008-5472.CAN-03-3341.
6. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001. 61:3225-3229. PMID:11309270.
7. Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, et al. DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int J Cancer 2003. 107:970-975. PMID:14601057. http://dx.doi.org/10.1002/ijc.11508.
8. Gormally E, Caboux E, Vineis P, Hainaut P. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res 2007. 635:105-117. PMID:17257890. http://dx.doi.org/10.1016/j.mrrev.2006.11.002.
9. Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin Cancer Res 2004. 10:6189-6193. PMID:15448006. http://dx.doi.org/10.1158/1078-0432.CCR-04-0597.
10. Hibi K, Nakao A. [Molecular detection of tumor DNA in the serum of colorectal cancer patients]. Nihon Rinsho 2003. 61(Suppl 7):197-200. PMID:14574881.
11. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001. 61:1659-1665. PMID:11245480.
12. Kohler C, Barekati Z, Radpour R, Zhong XY. Cell-free DNA in the circulation as a potential cancer biomarker. Anticancer Res 2011. 31:2623-2628. PMID:21778314.
13. van der Vaart M, Pretorius PJ. Is the role of circulating DNA as a biomarker of cancer being prematurely overrated? Clin Biochem 2010. 43:26-36. PMID:19747472. http://dx.doi.org/10.1016/j.clinbiochem.2009.08.027.
14. Brooks J, Cairns P, Zeleniuch-Jacquotte A. Promoter methylation and the detection of breast cancer. Cancer Causes Control 2009. 20:1539-1550. PMID:19768562. http://dx.doi.org/10.1007/s10552-009-9415-y.
15. Hoque MO, Feng Q, Toure P, Dem A, Critchlow CW, Hawes SE, et al. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J Clin Oncol 2006. 24:4262-4269. PMID:16908936. http://dx.doi.org/10.1200/JCO.2005.01.3516.
16. Brooks JD, Cairns P, Shore RE, Klein CB, Wirgin I, Afanasyeva Y, et al. DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study. Cancer Epidemiol 2010. 34:717-723. PMID:20627767. http://dx.doi.org/10.1016/j.canep.2010.05.006.
17. Swift-Scanlan T, Vang R, Blackford A, Fackler MJ, Sukumar S. Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort. Cancer Biol Ther 2011. 11:853-865. PMID:21383541. http://dx.doi.org/10.4161/cbt.11.10.15177.
18. Breiman L. Random forests. Mach Learn 2001. 45:5. http://dx.doi.org/10.1023/A:1010933404324.
19. Van De Voorde L, Speeckaert R, Van Gestel D, Bracke M, De Neve W, Delanghe J, et al. DNA methylationbased biomarkers in serum of patients with breast cancer. Mutat Res 2012. 751s:304-325. PMID:22698615.
20. Brait M, Ford JG, Papaiahgari S, Garza MA, Lee JI, Loyo M, et al. Association between lifestyle factors and CpG island methylation in a cancer-free population. Cancer Epidemiol Biomarkers Prev 2009. 18:2984-2991. PMID:19861513. http://dx.doi.org/10.1158/1055-9965.EPI-08-1245.
21. Zanetti-Dällenbach R, Wight E, Fan AX, Lapaire O, Hahn S, Holzgreve W, et al. Positive correlation of cell-free DNA in plasma/serum in patients with malignant and benign breast disease. Anticancer Res 2008. 28(2A):921-925. PMID:18507037.
22. Euhus DM, Bu D, Milchgrub S, Xie XJ, Bian A, Leitch AM, et al. DNA methylation in benign breast epithelium in relation to age and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2008. 17:1051-1059. PMID:18483325. http://dx.doi.org/10.1158/1055-9965.EPI-07-2582.
23. Fitzgibbons PL, Henson DE, Hutter RV. Cancer Committee of the College of American Pathologists. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Arch Pathol Lab Med 1998. 122:1053-1055. PMID:9870852.
24. Masnyk IJ, Sears M, Corle D, Go VL, Dunsmore M. Serum bank for biological markers for breast cancer. J Natl Cancer Inst 1983. 71:875-876. PMID:6578377.
25. Storey JD. The positive false discovery rate. J R Stat Soc Series B Stat Methodol 2002. 64:479-498. http://dx.doi.org/10.1111/1467-9868.00346.